What does a successful retirement look like? If it means financial security through steady income sources, then you can get ...

One of the latest voices weighing in is Jason Gerberry of Bank of America, who reiterated a Hold (Neutral) stance on Pfizer on February 4, 2026, setting a price objective of $27.00. This target sits ...

Amazon’s ( AMZN) free cash flow is likely to turn negative due to aggressive AI capital expenditures, while Google’s parent ...

The stock price of BridgeBio plunged 15% Thursday as Pfizer's reported decision to withdraw a Vyndamax patent in the European Union triggered fears of earlier generic entry in the blockbuster ...

In 2025, Pfizer PFE upped its efforts to rebuild its pipeline through acquisitions. Pfizer invested around $9 billion in M&A ...

Pfizer today announced that the US Food and Drug Administration (FDA) has accepted and granted Priority Review for the ...

Roivant Sciences (ROIV) upgraded to Buy on strong Phase 2 BEACON data for brepocitinib; see pipeline upside, risks, and why ...

Anti-obesity Drugs Market Report 2026-2036 Visiongain's new report release on the growth of the Anti-obesity Drugs market.

TrumpRx is a direct-to-consumer marketplace that gives discounted drug prices direct from manufacturers. What could possibly ...

Pfizer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its Hympavzi hemophilia drug for two patient populations with significant medical need ...

TrumpRx, the Trump administration’s much-anticipated direct-to-consumer drug platform, went live on Thursday. However, it ...

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the company's supplemental Biologics License Application (sBLA) for HYMPAVZI® ...